Iron Deficiency Injectable Market Growth Opportunities: Insights from 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Iron Deficiency Injectable Industry Compare Between 2025 And 2029?

The iron deficiency injectable market has experienced considerable growth in recent years. Looking ahead, it is projected to expand from $14.06 billion in 2024 to $15.22 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.3%. Historically, this expansion can be ascribed to a high incidence of iron deficiency anemia requiring treatment, the growing population of bariatric surgery patients, the needs of pediatric and adolescent patients, and an increase in pregnancies.

The iron deficiency injectable market size is projected to experience significant expansion in the coming years. It is forecasted to reach $22.81 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.6%. This anticipated growth during the forecast period is primarily driven by factors such as the increasing geriatric population, global health initiatives, various government initiatives, the growing number of treatments for chronic conditions, and the need for rapid iron replenishment. Prominent trends expected in this period include advances in iron formulations, the integration of digital health solutions, continuous advancements in iron deficiency injectable therapy, and the increasing adoption of iron-based drugs.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12907&type=smp

What Are The Top Growth Drivers Impacting The Iron Deficiency Injectable Market Outlook?

The rising incidence of Polycystic Ovary Syndrome (PCOS) is anticipated to boost the growth of the iron deficiency injectables market moving forward. PCOS is defined as a common hormonal disorder impacting individuals with ovaries, predominantly women of reproductive age. The syndrome is stated to result in iron overload, which subsequently causes excessive blood loss during menstruation and renders patients anemic, a condition treatable with injectable iron deficiency medications. As an illustration, the World Health Organization, a US-based specialized health agency, reported in June 2023 that polycystic ovary syndrome (PCOS) globally affects an estimated 8–13% of reproductive-aged women, with 70% of these cases remaining undiagnosed. Consequently, the widespread occurrence of polycystic ovary syndrome (PCOS) is propelling the expansion of the iron deficiency injectables market.

How Is The Iron Deficiency Injectable Market Classified Into Different Segments?

The iron deficiency injectablemarket covered in this report is segmented –

1) By Type: Iron Dextran; Iron Sucrose; Ferric Carboxymaltose

2) By Branded or Generics: Branded; Generics

3) By Application: Chronic Kidney Disease; Inflammatory Bowel Disease; Cancer; Other Applications

4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users

Subsegments:

1) By Iron Dextran: Low Molecular Weight Iron Dextran; High Molecular Weight Iron Dextran

2) By Iron Sucrose: Venofer

3) By Ferric Carboxymaltose: Injectafer; Ferinject

Which Competitive Trends Are Defining The Iron Deficiency Injectable Market Structure?

Leading companies in the iron deficiency injectables market are developing new treatments, such as INJECTAFER, to maintain their market position. For instance, in June 2023, Daiichi Sankyo Company, a US-based healthcare company, and American Regent Inc., a US-based injectables manufacturer, introduced INJECTAFER (ferric carboxymaltose injection) for iron deficiency, which had received approval from the Food And Drug Administration, a US-based government agency. This product is notable as the first and only intravenous iron replacement therapy to gain FDA approval for adult patients experiencing chronic and progressive heart failure. INJECTAFER was studied in over 40 clinical trials, involving more than 8,800 participants from various countries. This recent approval further strengthens INJECTAFER’s successful and demonstrated application in these patient populations, including both adult and pediatric patients with iron-deficient anemia and heart failure.

Which Industry Leaders Are Driving Innovation Across The Iron Deficiency Injectable Market?

Major companies operating in the iron deficiency injectable market are Daiichi Sankyo Company Limited, Pfizer Inc., Aetna Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, AstraZeneca PLC, GSK PLC, Fresenius Medical Care, Teva Pharmaceutical Industries Ltd., Mylan N.V., B Braun Medical Inc., Sandoz, Fresenius Kabi AG, Cipla Limited, Emcure Pharmaceuticals Ltd., AMAG Pharmaceuticals Inc., Luitpold Pharmaceuticals Inc., Akebia Therapeutics Inc., Covis Pharma GmbH, Keryx Biopharmaceuticals Inc., Rockwell Medical Inc., American Regent Inc., Galen Medical Group.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/iron-deficiency-injectable-global-market-report

How Do Regional Market Performances Compare Within The Iron Deficiency Injectable Industry?

North America was the largest region in the iron deficiency injectable market in 2024. The regions covered in iron deficiency injectable market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Iron Deficiency Injectable Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12907&type=smp

Browse Through More Reports Similar to the Global Iron Deficiency Injectable Market 2025, By The Business Research Company

Hemoglobin A1C Testing Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-testing-devices-global-market-report

Hemoglobin Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795